Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
暂无分享,去创建一个
Ava Kwong | Kent-Man Chu | K. Chu | S. Law | H. Jin | R. Poon | Hongchuan Jin | W. Law | A. Kwong | E. Ma | V. Shin | R. Pang | Enders K. O. Ng | Edmond S. K. Ma | Roberta Pang | D. Chua | E. Ng | Vivian Y. Shin | Ronnie T. P. Poon | R. Li | C. Leung | Candy P. H. Leung | Hong Chuan Jin | Rufina Li | Daniel Chua | W. L. Law | Simon Y. K. Law | Wai-Lun Law | E. Ng | W. Law
[1] Nicola J. Armstrong,et al. Haemolysis during Sample Preparation Alters microRNA Content of Plasma , 2011, PloS one.
[2] W. De,et al. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14) , 2011, Oncogene.
[3] A. Jemal,et al. Global Cancer Statistics , 2011 .
[4] Sota Asaga,et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. , 2011, Clinical chemistry.
[5] Brigitte Rack,et al. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.
[6] Hua Zhao,et al. A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer , 2010, PloS one.
[7] C. O'Morain,et al. Gastric retention and wireless capsule endoscopy in adults: a modified technique for direct duodenal deployment , 2010, Gut.
[8] H. Heneghan,et al. Systemic microRNAs: novel biomarkers for colorectal and other cancers? , 2010, Gut.
[9] Michael J Kerin,et al. Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer , 2010, Annals of surgery.
[10] Wei Shi,et al. Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas , 2010, Clinical Cancer Research.
[11] Y. Mo,et al. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. , 2010, Cancer research.
[12] G. Salles,et al. Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation. , 2009, Leukemia research.
[13] T. Brunner,et al. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. , 2009, Cancer research.
[14] Ulus Atasoy,et al. Circulating microRNAs in breast cancer and healthy subjects , 2009, BMC Research Notes.
[15] Tao Yu,et al. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster , 2009, Journal of experimental & clinical cancer research : CR.
[16] Jackeline Agorreta,et al. microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells , 2009, Clinical Cancer Research.
[17] Hailong Wu,et al. p53 represses c-Myc through induction of the tumor suppressor miR-145 , 2009, Proceedings of the National Academy of Sciences.
[18] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[19] Hansjuerg Alder,et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. , 2009, Gynecologic oncology.
[20] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[21] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[22] Olga Kovalchuk,et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin , 2008, Molecular Cancer Therapeutics.
[23] William Ignace Wei,et al. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.
[24] C. Croce,et al. MiR-15a and miR-16-1 cluster functions in human leukemia , 2008, Proceedings of the National Academy of Sciences.
[25] T. Leung,et al. Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.
[26] George A Calin,et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.
[27] N. Miller,et al. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer , 2008, BMC Molecular Biology.
[28] Asli Silahtaroglu,et al. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. , 2007, Cancer research.
[29] Renato Baserga,et al. Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells* , 2007, Journal of Biological Chemistry.
[30] Leonard D. Goldstein,et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.
[31] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[32] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[33] N. Perkins,et al. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. , 2006, American journal of epidemiology.
[34] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[35] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[36] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[37] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[38] M. Duffy,et al. CA 15-3 and Related Mucins as Circulating Markers in Breast Cancer , 1999, Annals of clinical biochemistry.
[39] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[40] Martin W. Bunder,et al. The inconsistency of , 1976, Journal of Symbolic Logic.